Anandamides Inhibit Binding to the Muscarinic Acetylcholine Receptor
- 1 January 1999
- journal article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 13 (1-2), 55-62
- https://doi.org/10.1385/jmn:13:1-2:55
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoidJournal of Lipid Research, 1997
- Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to the muscarinic receptorBrain Research, 1996
- (R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic StabilityJournal of Medicinal Chemistry, 1994
- Stimulation of arachidonic acid release and inhibition of mitogenesis by cloned genes for muscarinic receptor subtypes stably expressed in A9 L cells.Proceedings of the National Academy of Sciences, 1988
- The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitroBrain Research Bulletin, 1987
- Cannabinoid pharmacology.1986
- A Critical Review of the Role of the Cholinergic System in Human Memory and CognitionaAnnals of the New York Academy of Sciences, 1985
- CHARACTERIZATION OF NICOTINE BINDING IN MOUSE-BRAIN AND COMPARISON WITH THE BINDING OF ALPHA-BUNGAROTOXIN AND QUINUCLIDINYL BENZILATE1982
- Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization.Journal of Biological Chemistry, 1978
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEThe Lancet, 1976